| Theresa Thuy Dacio, SLP | |
|
5475 E La Palma Ave Ste 206, Anaheim, CA 92807-2075 | |
| (909) 636-8125 | |
| Not Available |
| Full Name | Theresa Thuy Dacio |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 3 Years |
| Location | 5475 E La Palma Ave Ste 206, Anaheim, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285386920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 16422 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Instrumental Speech Language Pathology Professionals Inc | 4385065903 | 4 |
News Archive
In testimony before the Department of Health and Human Services Drug Importation Task Force, CVS/pharmacy Chairman, President and CEO Tom Ryan called on Congress and the Administration to quickly establish a means for consumers to legally and safely import prescription drugs.
According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-lineage leukemia (MLL). MLL is the most common form of leukemia in babies. The study appeared in the journal Nature where scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151.
Researchers at the ANU John Curtin School of Medical Research have identified proteins that determine which mice succumb to mousepox and which do not. The new insights into the immune response of mice to the mousepox virus could enable scientists to improve treatment for poxvirus infections, including smallpox.
An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. In just a few years' time, Ipilumumab could be approved as a treatment for the world's third-most common type of cancer.
Warm weather may hinder cognitive performance in people with multiple sclerosis (MS), according to results of a Kessler Foundation study e-published online ahead of print by Neurology. An accompanying editorial by Meier & Christodoulou, MS and heat: The smoke and the fire, details the study's unique aspects, ie, longitudinal followup in a cohort with apparently quiescent disease.
› Verified 8 days ago
| Provider Name | Instrumental Speech Language Pathology Professionals Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396372686 PECOS PAC ID: 4385065903 Enrollment ID: O20200605001133 |
News Archive
In testimony before the Department of Health and Human Services Drug Importation Task Force, CVS/pharmacy Chairman, President and CEO Tom Ryan called on Congress and the Administration to quickly establish a means for consumers to legally and safely import prescription drugs.
According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-lineage leukemia (MLL). MLL is the most common form of leukemia in babies. The study appeared in the journal Nature where scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151.
Researchers at the ANU John Curtin School of Medical Research have identified proteins that determine which mice succumb to mousepox and which do not. The new insights into the immune response of mice to the mousepox virus could enable scientists to improve treatment for poxvirus infections, including smallpox.
An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. In just a few years' time, Ipilumumab could be approved as a treatment for the world's third-most common type of cancer.
Warm weather may hinder cognitive performance in people with multiple sclerosis (MS), according to results of a Kessler Foundation study e-published online ahead of print by Neurology. An accompanying editorial by Meier & Christodoulou, MS and heat: The smoke and the fire, details the study's unique aspects, ie, longitudinal followup in a cohort with apparently quiescent disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Thuy Dacio, SLP 5407 E Indian Wells Ct, Anaheim, CA 92807-4613 Ph: (909) 636-8125 | Theresa Thuy Dacio, SLP 5475 E La Palma Ave Ste 206, Anaheim, CA 92807-2075 Ph: (909) 636-8125 |
News Archive
In testimony before the Department of Health and Human Services Drug Importation Task Force, CVS/pharmacy Chairman, President and CEO Tom Ryan called on Congress and the Administration to quickly establish a means for consumers to legally and safely import prescription drugs.
According to British scientists a potential new drug from GlaxoSmithKline could treat mixed-lineage leukemia (MLL). MLL is the most common form of leukemia in babies. The study appeared in the journal Nature where scientists from the British drugmaker collaborating with the charity Cancer Research UK (CRUK) and Cellzome AG found that the experimental drug, called I-BET151.
Researchers at the ANU John Curtin School of Medical Research have identified proteins that determine which mice succumb to mousepox and which do not. The new insights into the immune response of mice to the mousepox virus could enable scientists to improve treatment for poxvirus infections, including smallpox.
An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. In just a few years' time, Ipilumumab could be approved as a treatment for the world's third-most common type of cancer.
Warm weather may hinder cognitive performance in people with multiple sclerosis (MS), according to results of a Kessler Foundation study e-published online ahead of print by Neurology. An accompanying editorial by Meier & Christodoulou, MS and heat: The smoke and the fire, details the study's unique aspects, ie, longitudinal followup in a cohort with apparently quiescent disease.
› Verified 8 days ago
Kentessa Birner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 160 S Old Springs Rd, Suite 100, Anaheim, CA 92808 Phone: 714-282-8852 Fax: 714-282-8876 | |
Ms. Sarah Yi, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 217 W Cerritos Ave, Anaheim, CA 92805 Phone: 714-776-1231 | |
Elizabeth Welsh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1360 S Anaheim Blvd Ste 150, Anaheim, CA 92805 Phone: 714-776-1231 | |
Ms. Deborah Fung Wai Lau, M.A.. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 W Cerritos Ave, Anaheim, CA 92805 Phone: 714-776-1231 Fax: 714-776-0802 | |
Katelyn Dean, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2717 E Maverick Ave, Anaheim, CA 92806 Phone: 714-350-1942 | |
Nicole Versales, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 S Chaparral Ct Ste 110, Anaheim, CA 92808 Phone: 714-282-8852 Fax: 714-282-8876 | |
Eun Hwa Lee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 W Cerritos Ave, Anaheim, CA 92805 Phone: 714-776-1231 Fax: 714-776-0802 |